Clinical Trial Update: Validation of a New Device to Measure Neuromuscular Disease Progression

View source ↗

Summary

A completed clinical trial validating a new device intended to measure progression in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Amyotrophic Lateral Sclerosis & Other Neuromuscular Disorders | Status: COMPLETED